Exagen Inc.XGNNASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P13
Within normal range
vs 5Y Ago
-2.2x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-60.48%
Q3 2025-17.87%
Q2 202521.84%
Q1 20250.53%
Q4 202427.45%
Q3 2024-80.25%
Q2 202413.85%
Q1 202441.66%
Q4 2023-1.54%
Q3 2023-3.13%
Q2 202336.22%
Q1 202346.82%
Q4 2022-85.38%
Q3 202244.42%
Q2 2022-45.30%
Q1 2022-54.76%
Q4 20213.84%
Q3 2021-13.27%
Q2 2021-3.14%
Q1 2021-101.63%
Q4 202027.07%
Q3 2020-10.80%
Q2 202034.55%
Q1 2020-82.68%
Q4 2019-32.50%
Q3 201910.50%
Q2 2019-28.60%
Q1 2019-1141.06%
Q4 201886.67%
Q3 201822.82%
Q2 201831.02%
Q1 20180.00%
Q4 20156.72%
Q3 2015-3.13%
Q2 2015-8.77%
Q1 2015-34.49%
Q4 201445.13%
Q3 2014-2.16%
Q2 2014-1.35%
Q1 2014-19.53%